US researchers have developed a novel, low-cost DNA-based vaccine that may not only provide protection against existing variants of coronavirus, but also against its future strains.

The vaccine, which will cost about $1 a dose, has shown promising results in early animal testing, said the team from University of Virginia and Virginia Polytechnic Institute and State University.

"Our new platform offers a new route to rapidly produce vaccines at very low cost that can be manufactured in existing facilities around the world, which should be particularly helpful for pandemic response," said Steven L. Zeichner from the UVA Health. The study is detailed in the journal PNAS.



Source link